Keywords: رتیگوتین; SÃndrome de piernas inquietas; Hemodiálisis; Rotigotina; Restless legs syndrome; Haemodialysis; Rotigotine;
مقالات ISI رتیگوتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رتیگوتین; Restless legs syndrome; Hemodialysis; Rotigotine; SÃndrome de piernas inquietas; Hemodiálisis; Rotigotina;
Keywords: رتیگوتین; UVVDNNVPUQCRAL-WEDFXWGISA-N; FCYPSYZMQCNBQK-AAMBQHNMSA-N; XYZHWGUHOBLASO-KIHJKWKTSA-M; HFCNJLFDKREQNK-BEPVFTBQSA-N; FFXCDKARFNOMKV-UHFFFAOYSA-N; GQDGIYQETPUKCK-XVSRHIFFSA-N; Rotigotine; Chiral amine; Asymmetric hydrogenation;
Keywords: رتیگوتین; Restless legs syndrome; Rotigotine; Augmentation; Pramipexole; Ropinirole;
Keywords: رتیگوتین; Chinese; Parkinson's disease; Rotigotine; Treatment;
Keywords: رتیگوتین; Parkinson's disease; Rotigotine; Polysomnography; Sleep; REM;
Keywords: رتیگوتین; pharmacokinetics; rotigotine; safety; tolerability;
Keywords: رتیگوتین; Restless legs syndrome; Augmentation; Dopamine agonist; Pramipexole; Ropinirole; Rotigotine; Methadone; Gabapentin;
Keywords: رتیگوتین; Cabergoline; Rotigotine; Tacrine; Tremulous jaw movement; c-Fos; Parkinsonism
Keywords: رتیگوتین; Rotigotine; Transdermal drug delivery; Response surface analysis technique; Factorial design; Hydrogels
Keywords: رتیگوتین; Rotigotine; Parkinson's disease; Dyskinesia; Levodopa;
Keywords: رتیگوتین; Dopamine agonists; Pramipexole; Ropinirole; Rotigotine; Prolonged release; EquivalenceAgonistas dopaminérgicos; Pramipexol; Ropinirol; Rotigotina; Liberación prolongada; Equivalencia
Keywords: رتیگوتین; Dopamine agonist; Elderly; Parkinson's disease; Rotigotine; Safety;
Keywords: رتیگوتین; Dopamine agonist; Rotigotine; Restless legs syndrome; Transdermal delivery; Clinical practice; RLS-6;
Keywords: رتیگوتین; Restless legs syndrome; Rotigotine; Clinical trial; International Restless Legs Study Group rating scale; Pittsburgh Sleep Quality Index; Japan;
Keywords: رتیگوتین; Parkinson's disease; Dyskinesia; Wearing off; Drug delivery; Rotigotine;
Rotigotine, a dopamine receptor agonist, increased BDNF protein levels in the rat cortex and hippocampus
Keywords: رتیگوتین; Rotigotine; Dopamine receptors; BDNF; Synaptic proteins;
Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects
Keywords: رتیگوتین; bioequivalence; Chinese; dopamine agonist; pharmacokinetics; rotigotine; tolerability; transdermal delivery;
Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor
Keywords: رتیگوتین; Hypokinesia; Night-time; Parkinson's disease; Rotigotine; Wearable technology; Inertial sensors;
Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
Keywords: رتیگوتین; Advanced-stage Parkinson's disease; Chinese; Rotigotine; Treatment;
Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial
Keywords: رتیگوتین; Chronic kidney disease (CKD); dopamine agonist; rotigotine; restless legs syndrome (RLS); periodic limb movements (PLM); periodic limb movement index (PLMI); hemodialysis; end-stage renal disease (ESRD); randomized controlled trial (RCT);
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors
Keywords: رتیگوتین; Rotigotine hydrochloride (PubChem CID: 180335); Pramipexole dihydrochloride (PubChem CID: 119569); SCH 39166 (PubChem CID: 16759171); Eticlopride (PubChem CID: 6917728); Dopamine D1 receptor; Dopamine D2 receptor; Parkinson's disease; Pramipexole; Rotigot
Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial
Keywords: رتیگوتین; Dopamine agonist; Gastrointestinal; Non-motor; Parkinson's disease; Rotigotine;
Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture
Keywords: رتیگوتین; Parkinson disease; Rotigotine; Glutamate excitotoxicity; PI3K/Akt pathway; Neuroprotection
Synthesis and SAR study of a novel series of dopamine receptor agonists
Keywords: رتیگوتین; Dopamine receptor agonist; Parkinson's disease; Rotigotine;
Agonistas dopaminérgicos en la enfermedad de Parkinson
Keywords: رتیگوتین; Agonistas dopaminérgicos; Pramipexol; Ropinirol; Rotigotina; Liberación prolongada; Equivalencia; Dopamine agonists; Pramipexole; Ropinirole; Rotigotine; Prolonged release; Equivalence;
From Bench to Bedside: An Overview of Rotigotine for the Treatment of Restless Legs Syndrome
Keywords: رتیگوتین; augmentation; dopamine agonists; restless legs syndrome; rotigotine; transdermal;
Rotigotine vs ropinirole in advanced stage Parkinson's disease: AÂ double-blind study
Keywords: رتیگوتین; Parkinson's disease; Treatment; Randomized trial; Rotigotine; Ropinirole;
Rotigotine and specific non-motor symptoms of Parkinson's disease: Post hoc analysis of RECOVER
Keywords: رتیگوتین; Parkinson's disease; Non-motor symptoms; Fatigue; Mood; Rotigotine;
Outcomes of Rotigotine Clinical Trials
Keywords: رتیگوتین; Rotigotine; Parkinson's disease; Clinical trials; Motor symptoms; Nonmotor symptoms;
The Development of the Rotigotine Transdermal Patch
Keywords: رتیگوتین; Dopamine receptor agonist; Parkinson's disease; Rotigotine; Transdermal; Continuous delivery;
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension study
Keywords: رتیگوتین; Parkinson's disease; Safety; Long term; Rotigotine; Transdermal;
Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson's disease: Results from a 1-year, open-label extension of the RECOVER study
Keywords: رتیگوتین; AE; adverse event; ASR; application site reaction; BDI-II; Beck Depression Inventory; DA; dopamine agonist; NADCS; Nocturnal Akinesia, Dystonia and Cramps score; NMSS; non-motor symptoms scale; PD; Parkinson's disease; PDSS-2; modified Parkinson's Dis
Augmentation in the treatment of restless legs syndrome with transdermal rotigotine
Keywords: رتیگوتین; Augmentation; Dopamine agonist; Restless legs syndrome; Rotigotine; Transdermal delivery; Loss of efficacy;
High compliance with rotigotine transdermal patch in the treatment of idiopathic Parkinson's disease
Keywords: رتیگوتین; Dopamine agonist; Parkinson's disease; Rotigotine; Transdermal patch; Treatment compliance;
Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or l-DOPA in MPTP-treated common marmosets
Keywords: رتیگوتین; Rotigotine; l-DOPA; Continuous delivery; Dyskinesia; MPTP; Primates; Parkinson's disease
Comparing different salt forms of rotigotine to improve transdermal iontophoretic delivery
Keywords: رتیگوتین; Solubility; Transdermal; Iontophoresis; Rotigotine; Salt form; Modeling
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study
Keywords: رتیگوتین; Dopamine agonist; Idiopathic restless legs syndrome; Periodic limb movement; Polysomnography; Rotigotine; Sleep; Transdermal patch
Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction
Keywords: رتیگوتین; Rotigotine; l-DOPA; Continuous delivery; Dyskinesia; MPTP; Primates; Parkinson's disease
Simultaneous enantioseparation of antiparkinsonian medication Rotigotine and related chiral impurities by capillary zone electrophoresis using dual cyclodextrin system
Keywords: رتیگوتین; Capillary electrophoresis; Chiral separation; Dual cyclodextrin; Enantiomeric impurity; Pharmaceutical analysis; Rotigotine
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep–wake cycle in the rat
Keywords: رتیگوتین; Rotigotine; Parkinson's disease; Sleep; Continuous dopaminergic stimulation; Dyskinesia; Nomifensine
One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome
Keywords: رتیگوتین; Restless legs syndrome; Therapy; Dopamine agonist; Rotigotine; Transdermal patch; Long-term therapy; Open-label design
Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
Keywords: رتیگوتین; Restless legs syndrome; Therapy; Dopamine agonist; Rotigotine; IRLS; RLS-6; CGI; Augmentation
Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection
Keywords: رتیگوتین; Rotigotine; Microdialysis; Electrochemical detection; Liquid chromatography
Antidepressant properties of rotigotine in experimental models of depression
Keywords: رتیگوتین; Rotigotine; Dopamine agonist; Animal models depression; Parkinson's disease